Tech Company Inital Public Offerings
Sigilon Therapeutics IPO
Sigilon Therapeutics, operating out of Cambridge, debuted as a public company on 12/3/2020.
Transaction Overview
Company Name
Announced On
12/3/2020
Transaction Type
IPO
Amount
$126,000,000
Proceeds Purpose
We intend to use the net proceeds from this offering, together with cash on hand, for our Phase 1/2 clinical trials and ongoing development for SIG-001 for treatment of Hemophilia A, IND-enabling studies and the potential initiation of clinical studies for certain of our other current programs, to continue to scale our GMP manufacturing processes for our lead product candidates SIG-001 and SIG-005, continued advancement of our platform technologies and discovery-stage research for other potential programs and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Binney St. 600
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Sigilon Therapeutics (Nasdaq: SGTX) was founded and created by Flagship Pioneering. Sigilon Therapeutics is developing treatments for chronic diseases using new biomaterials, developed at the Massachusetts Institute of Technology (MIT), that can shield implanted cells from immune attack.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rogerio Vivaldi
Chief Financial Officer
Glenn Reicin
Chief Medical Officer
Deya Corzo
Chief Technical Officer
David Peritt
Vice President
Hozefa Bandukwala
Vice President
Olivia Kelly
VP - Bus. Development
Anne Altmeyer
VP - Engineering
Susan Drapeau
VP - Finance
Josias Pontes
VP - General Counsel
Melodie Henderson
VP - General Counsel
Matthew Kowalsky
VP - Human Resources
Vanya Sagar
VP - Manufacturing
Martha Rook
VP - Operations
Devyn Smith
Browse more venture capital transactions:
Prev: 12/3/2020: Dayforward venture capital transaction
Next: 12/3/2020: ConnexPay venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs